跳至主要内容
临床试验/NCT05213832
NCT05213832已完成2 期

Effect of Inhalatory Sedation on Cerebral Perfusion in Subarachnoid Hemorrhage

A.O.U. Città della Salute e della Scienza1 个研究点 分布在 1 个国家目标入组 11 人开始时间: 2020年6月26日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
11
试验地点
1
主要终点
Cerebral blood flow recondtion

研究概览

简要总结

The aim of this study is to evaluate the effect of inhalational sedation on cerebral perfusion in patients with SAH.

It will evaluate whether the administration of isofluorane, by inducing direct vasodilation in the cerebral parenchyma, can improve the cerebral perfusion rates.

Perfusional CT will be used to study the variation of cerebral blood flow to rule out the vasodilatory effect on territories with different cerebrovascular reactivity aggravating the phenomena of distrectual hypoperfusion (theft theory).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 64 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18 years old
  • Diagnosis of non-traumatic SAH
  • Neurological and/or systemic presentation that requires support of vital functions and sedation. This occurs for a WFNS score (World Federation of Neurosurgical Societies) ≥
  • Possibility of ICP monitoring through EVD which is necessary in case of acute hydrocephalous. In case of the neurosurgeon do not indicate the positioning of the EVD, an intraparenchymal catheter will be positioned for the ICP monitoring.
  • Patients with vasospasm (area of cerebral blood flow under 30% of the best value detected in the brain of the patients at the first CT scan). This exam will be performed at 2° - 3° day post event.
  • Acceptance of informed consent.

排除标准

  • Documented outcomes of cerebrovascular disease
  • Patients with acute heart failure related to ESA
  • State of pregnancy
  • Patients with CLCR < 30 mL/min

研究组 & 干预措施

Inhalatory group

Experimental

Patience with severe SAH (WFNS > 3) are enrolled in the study. In these patients we administered a inhalatory dose of Isofluorane

干预措施: Isoflurane Inhal Soln (Drug)

结局指标

主要结局

Cerebral blood flow recondtion

时间窗: 20 minutes

The percentage of subjects who had a flow recondition at the second CT at least 50% of the best value detected in the first perfusion CT scan

次要结局

  • Changes in blood pressure during isoflurane delivery(20 minutes)
  • Changes in intracranial pressure during isoflurane delivery(20 minutes)

研究者

发起方
A.O.U. Città della Salute e della Scienza
申办方类型
Other
责任方
Principal Investigator
主要研究者

Maurizio Berardino

Director of Anesthesia and Intensive Care Unit Departement

A.O.U. Città della Salute e della Scienza

研究点 (1)

Loading locations...

相似试验